CHI Advisors »

Sagimet Biosciences Inc-a shares owned by CHI Advisors

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by CHI Advisors from 13F filings

Historical chart of CHI Advisors investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by CHI Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by CHI Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.1M 349k 8.80

More positions owned by CHI Advisors

Pliant Therapeutics (PLRX)
Repare Therapeutics Ord (RPTX)
Cullinan Oncology (CGEM)
Acelyrin (SLRN)
Orchard Therapeutics Spon Ads New
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ikena Oncology (IKNA)
Ultragenyx Pharmaceutical (RARE)
Compass Therapeutics (CMPX)
Mineralys Therapeutics (MLYS)
Inozyme Pharma (INZY)
Syros Pharmaceuticals Com New (SYRS)
Blueprint Medicines (BPMC)
Direxion Shs Etf Tr Daily S&p Biotec (LABD)

View all positions for CHI Advisors

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a